Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus
CPT: Pharmacometrics & Systems Pharmacology · 2023
DOI: 10.1002/psp4.12943 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2023. Verfasst von Kefeng Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Ribonucleosides. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Maribavir was approved by the US Food and Drug Administration for the treatment of patients aged ≥12 years and weighing ≥35 kg with posttransplant cytomegalovirus infection/disease refractory (with/without resistance) to valganciclovir, ganciclovir, cidofovir, or foscarnet, with an oral dose of 400 mg twice daily. With no pediatric clinical data available and difficulty in trial recruitment, population pharmacokinetic modeling and simulations were conducted to predict the pharmacokinetics and inform maribavir dosing in adolescents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
- ICON plc, Reading, UK.
Zitieren
APA
Sun, K., Hayes, S., Farrell, C., & Song, I. H. (2023). Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.12943
Vancouver
Sun K, Hayes S, Farrell C, Song IH. Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus. CPT: Pharmacometrics & Systems Pharmacology. 2023. doi:10.1002/psp4.12943
BibTeX
@article{Sun2023,
author = {Sun, Kefeng and Hayes, Siobhan and Farrell, Colm and Song, Ivy H},
title = {Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2023},
doi = {10.1002/psp4.12943}
}
EUVIMED